ll28 / iStockphoto.com
Frazier Healthcare Partners has been responsible for creating and investing in multiple biotech companies, developing products from novel antibiotics to cancer therapies. James Topper, Frazier’s managing general partner, explains the firm’s philosophy.
Bringing back big returns on investments is the main goal of venture capitalism. But for James Topper, managing general partner of Frazier Healthcare Partners, there is more that drove him to venturing into life sciences: he finds it rewarding to work with biotech companies as they release drugs that benefit patients.
“The thing I’m most proud of is having been involved in multiple successful venture capital investments in the biotech space together with my colleagues. Many of these have resulted in the development of drugs which have made it to the market and are now benefiting hundreds of thousands of patients,” says Topper.
“All our companies are regulated by the Food and Drug Administration (FDA) and ultimately have to pass scrutiny by that organisation to be successful for the long term.”
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
LSIPR 2017, James Topper, biotech, Frazier Healthcare Partners, venture capital, investment, drug development, antibiotics, cancer therapies,
